Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study Pharmaceutical Investing
SELLAS Life Sciences Announces Completion of Enrollment in Phase 2 Clinical Study of Nelipepimut-S Pharmaceutical Investing
Spectral Announces Publication of the post hoc analysis of EUPHRATES trial in Intensive Care Medicine Medical Device Investing
Chi-Med Announces First Commercial Launch of Fruquintinib Capsules (Elunate) Pharmaceutical Investing
Align Announces New iTero Updates and Connectivity to Improve Customer Experience and Workflow for Dental Practices Medical Device Investing
Acerus Provides Update on Continuing Commercial and R&D Achievements for NATESTO® Pharmaceutical Investing
Lexaria Bioscience Submits Application to Health Canada for Research License and Appoints Chief Legal Officer Cannabis Investing News
Life Science Big News Roundup: Relay Medical Commences User Studies on Pharmatrac Medication Management Technology; PreveCeutical Confirms Encouraging Results from Sol-gel Applicator Trials Life Science Investing News
